These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25261856)

  • 41. Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis.
    Costa J; Gromicho M; Pronto-Laborinho A; Almeida C; Gomes RA; Guerreiro ACL; Oliva A; Pinto S; de Carvalho M
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
    J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.
    Heckler I; Venkataraman I
    J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases.
    Costa J; Pronto-Laborinho A; Pinto S; Gromicho M; Bonucci S; Tranfield E; Correia C; Alexandre BM; de Carvalho M
    Sci Rep; 2020 Mar; 10(1):5649. PubMed ID: 32221402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
    Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression.
    Andrés-Benito P; Domínguez R; Colomina MJ; Llorens F; Povedano M; Ferrer I
    Aging (Albany NY); 2018 Sep; 10(9):2367-2382. PubMed ID: 30215603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative study of CSF neurofilament light and heavy chain protein in MS.
    Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
    Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
    Steinacker P; Fang L; Kuhle J; Petzold A; Tumani H; Ludolph AC; Otto M; Brettschneider J
    PLoS One; 2011; 6(8):e23600. PubMed ID: 21858182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofilaments in pre-symptomatic ALS and the impact of genotype.
    Benatar M; Wuu J; Lombardi V; Jeromin A; Bowser R; Andersen PM; Malaspina A
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):538-548. PubMed ID: 31432691
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma N-Glycome Signature of Down Syndrome.
    Borelli V; Vanhooren V; Lonardi E; Reiding KR; Capri M; Libert C; Garagnani P; Salvioli S; Franceschi C; Wuhrer M
    J Proteome Res; 2015 Oct; 14(10):4232-45. PubMed ID: 26334954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).
    Brettschneider J; Lehmensiek V; Mogel H; Pfeifle M; Dorst J; Hendrich C; Ludolph AC; Tumani H
    Neurosci Lett; 2010 Jan; 468(1):23-7. PubMed ID: 19853641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
    Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
    Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study.
    Martinelli I; Zucchi E; Simonini C; Gianferrari G; Bedin R; Biral C; Ghezzi A; Fini N; Carra S; Mandrioli J
    Eur J Neurol; 2024 Jan; 31(1):e16054. PubMed ID: 37679868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.